Target
Kallikrein-1
Ligand
BDBM357149
Substrate
n/a
Meas. Tech.
Kallikrein Assay
Ki
1.02±n/a nM
Citation
 Xu, JAli, AZhou, WGao, YEdmondson, SDMertz, ENeelamkavil, SFLiu, WSun, WShen, DHarper, BZhu, CBara, TLim, YYang, M Factor XIA inhibitors US Patent  US10214512 Publication Date 2/26/2019 
Target
Name:
Kallikrein-1
Synonyms:
KLK1 | KLK1_HUMAN | Kallikrein 1 | Kallikrein-1 | Kidney/pancreas/salivary gland kallikrein | Tissue kallikrein
Type:
Enzyme
Mol. Mass.:
28874.69
Organism:
Homo sapiens (Human)
Description:
P06870
Residue:
262
Sequence:
MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS
  
Inhibitor
Name:
BDBM357149
Synonyms:
(Z)-2-(24-Amino-4-OXO-11H-3-aza-1(4,2)-imidazola-2(1,2) -benzenacyclononaphane-9-yl)-5-(3-chloro-2,6-difluorophenyl)pyridine 1-oxide | US10214512, Example 108-a
Type:
Small organic molecule
Emp. Form.:
C26H22ClF2N5O2
Mol. Mass.:
509.935
SMILES:
Nc1ccc2-c3c[nH]c(n3)C(CCCCC(=O)Nc2c1)c1ccc(c[n+]1[O-])-c1c(F)ccc(Cl)c1F
Structure:
Search PDB for entries with ligand similarity: